(19)
(11) EP 1 641 821 A2

(12)

(88) Date of publication A3:
28.04.2005

(43) Date of publication:
05.04.2006 Bulletin 2006/14

(21) Application number: 04763048.8

(22) Date of filing: 29.06.2004
(51) International Patent Classification (IPC): 
C07K 14/47(1995.01)
 G01N 33/50(1980.01)
(86) International application number:
PCT/EP2004/007046
(87) International publication number:
WO 2005/003161 (13.01.2005 Gazette 2005/02)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 30.06.2003 US 484103 P

(71) Applicants:
  • Genova Ltd.
    Hamilton HM12 (BM)
  • Novartis Pharma GmbH
    1230 Vienna (AT)

    AT 

(72) Inventors:
  • ARGOUD-PUY, Guilaine GeneProt, Inc.
    CH-1217 Meyrin (CH)
  • BEDERR, Nassima GeneProt, Inc.
    CH-1217 Meyrin (CH)
  • BOUGUELERET, Lydie GeneProt, Inc.
    CH-1217 Meyrin (CH)
  • CUSIN, Isabelle GeneProt, Inc.
    CH-1217 Meyrin (CH)
  • MAHE, Eve GeneProt, Inc.
    CH-1217 Meyrin (CH)
  • NIKNEJAD, Anne GeneProt, Inc.
    CH-1217 Meyrin (CH)
  • REFFAS, Samia GeneProt, Inc.
    CH-1217 Meyrin (CH)
  • SAUDRAIS, Cedric GeneProt, Inc.
    CH-1217 Meyrin (CH)

(74) Representative: Leon, Susanna Iris et al
Novartis AG Corporate Intellectual Property P.O. Box
4002 Basel
4002 Basel (CH)

   


(54) HUMAN SECRETED PROTEINS